Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> China Pharma Providers
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Pharma Providers
Type:
CRO-Clinical
Title:
InCROM China
Chinese
CSertification:
n/a
International
Certification:
n/a
Primary Location:
Shanghai
China
Contact Info:
Room 603, Building C, Hi-Tech Building, 900 Yishan Road, Shanghai 200233, China
Tel: +86 21 5423 4290 Fax: +86 21 5423 4292
Email: china-info@incrom.com; info@incrom.com.cn
Webpage:
www.incrom.com
HQ
Contact Info:
InCROM JAPAN
Senri Sunplaza 4-12-11 Kasuga, Suita Shi Osaka, Japan 565-0853
Tel: +81 6 6192 0002 Fax: +81 6 6192 0221
Email: japan-info@incrom.com
5-15-5 Shinjuku, Shinjuku Ku Tokyo, Japan 160-0022
Tel: +81 3 5369 3301 Fax: +81 3 5369 3305
Additional
Contact Info:
n/a
Description:
InCROM China is a CRO proficient in providing comprehensive services and support to all types of clinical studies, regardless of study size, sponsor's country of origin and study type. Being part of the experienced InCROM Group, InCROM China is highly capable of conducting clinical studies in accordance with international standards.
InCROM China is affiliated with 7 biochemical laboratories in Shanghai and Beijing, thus ensuring proper and prompt processing of clinical samples at all times. Client satisfaction is enhanced as sponsors are given more flexibility in regards to location, depending on factors such as cost efficiency and study timelines.
InCROM Group initially started in Japan in 1983 and was formed by the expansion of its parent company, Rabiton Institute Inc.. In 24 years, InCROM Group has achieved year on year growth. It has evolved from a domestic company that mainly supported Phase I clinical studies in Japan to a global corporation proficient in providing total support to its international affiliated network in Phase I - IV studies. To date, over 1200 protocols have been achieved via InCROM Group and over 28,000 volunteers are registered.
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit